Company news

Bioventus Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026

July 29, 2026

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

June 2, 2026

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

April 30, 2026

Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

April 28, 2026

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

March 4, 2026

Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026

February 24, 2026

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026

Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference

November 25, 2025

Bioventus Reports Third Quarter Financial Results

November 4, 2025

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

October 28, 2025

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 3, 2025

Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

August 7, 2025

Bioventus Reports Second Quarter Financial Results

August 6, 2025

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

August 4, 2025

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

July 30, 2025

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

July 29, 2025

Bioventus Reports First Quarter Financial Results

May 6, 2025

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

April 28, 2025

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

March 11, 2025

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

February 28, 2025

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

January 1, 2025

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

October 28, 2024

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

September 30, 2024

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

August 6, 2024

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

July 29, 2024

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

April 28, 2024

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

March 11, 2024

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

March 3, 2024

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

January 11, 2024

Bioventus Names Robert Claypoole as President and Chief Executive Officer

December 18, 2023

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

December 5, 2023

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

November 6, 2023

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

October 30, 2023

Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

August 7, 2023

Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

July 31, 2023

Bioventus Completes Divestiture of its Wound Business

May 22, 2023

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

May 14, 2023

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

May 10, 2023

Bioventus Announces Divestiture of its Wound Business

May 9, 2023

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

May 2, 2023

Bioventus Announces CEO Leadership Change

April 4, 2023

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

March 30, 2023

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

March 28, 2023

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

March 15, 2023

Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition

February 27, 2023

Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

November 20, 2022

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

November 15, 2022

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

November 7, 2022

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022

October 30, 2022

Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 33 decks. Every deck is listed under its year.